ANDREA MOON: Open Payments
NPI 1710054143 · CASTLE PINES, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 33 payments from 17 companies in 2025. Trend: 2023 $17 · 2024 $143 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $95 |
| Novo Nordisk Inc | 5 | $90 |
| ABBVIE INC. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $35 |
| ABIOMED | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: Wegovy, NURTEC ODT, LEQVIO, UBRELVY, SHINGRIX, MOUNJARO, KRYSTEXXA, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
